Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Treatment for latent TB infection substantially reduces the risk that TB infection will progress to disease. Certain groups are at very high risk of developing TB disease if infected. Identifiable population groups at high risk for TB vary in time and geographic area, depending on unique and changing TB related demographics.
Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.
The baseline estimate was revised from 64.3% (2007) to 68.1% (2007). The former estimate was submitted as preliminary data. The latter estimate reflects the final national estimate. The target was not revised.
Added "and initiated treatment" to the numerator and denominator for clarity because not everyone with LTBI actually start treatment.
Added phrases to the objective statement for clarity: Increase the percentage of *contacts to sputum smear-positive *tuberculosis* cases who complete treatment after being diagnosed with latent tuberculosis infection *(LTBI) and initiated treatment for LTBI.*
Additional resources about the objective.
This hyperlink will direct you to a non-governmental Website or application.
The appearance of external hyperlinks does not constitute endorsement by the United
States Department of Health & Human Services (HHS) of the hyperlinked Website
or application, or the information, products or services contained therein. Such
hyperlinks are provided consistent with the intended purpose of this HHS Website.
Visitors to the hyperlinked Website or application will be subject to the Website
or application's privacy policies. These practices may be different than those of
this HHS Website.
You will be redirected to: link